
Mobilising capital to help Australian health innovation scale
Australian health and medtech innovation has enormous potential, but too often the pathway from early promise to global scale remains difficult to navigate. HESTA’s anchor investment in Synthesis Capital marks an important step in strengthening the capital pathways, specialist support and ecosystem conditions needed to help high-potential ventures grow.
Synthesis Capital has been established as an integrated investment platform focused on early-stage deep health technology. The platform brings together capital, venture-building capability, sector expertise and global networks to support high-potential companies translating breakthrough health technologies into global markets.
For the Menzies Leadership Foundation, this announcement is significant because it demonstrates the kind of systems entrepreneurship Australia needs more of: connecting leadership, specialist expertise, trusted networks and aligned capital to help innovation scale.
Since 2018, the Foundation has supported science entrepreneurship through its partnership with MedTech Actuator, helping researchers, clinicians and emerging health innovators build the capability, confidence and networks required to move ideas towards real-world impact. This work has always been about more than individual ventures. It has been about strengthening the ecosystem around innovation so that promising ideas are not left to navigate complex pathways alone.
Synthesis Capital represents an important next step in that ecosystem-building journey.
Across Australia and the Asia-Pacific, exceptional health and medtech innovation is emerging from hospitals, universities, research institutes and founder-led companies. Yet many ventures still face a familiar challenge: the gap between breakthrough science, specialist expertise and the capital required to reach commercial scale.
The Foundation has played a catalytic role in helping create the conditions for this next phase —by providing capital, supporting leadership development, backing ecosystem capability, convening partners, and helping open routes to further capital and scale.
We believe This is where philanthropy can play a powerful role: not by acting alone, but by helping connect the actors, infrastructure and confidence needed for systems to shift.
HESTA’s anchor investment provides significant institutional validation for this approach. It signals confidence in the quality of Australia and Asia-Pacific’s health innovation pipeline, and in the role specialist investment platforms can play in helping early-stage companies grow.
Menzies Leadership Foundation CEO Liz Gillies said the announcement reflects the importance of building the conditions around innovation, not just celebrating individual breakthroughs.
“Health and medtech innovation does not scale through talent alone. It requires connected systems — leaders who can navigate complexity, investors who understand long-term value, and partnerships that help ideas move from promise to impact,” Ms Gillies said.
“This is a powerful example of systems entrepreneurship in action. It shows what becomes possible when catalytic capital, capability and connectivity are brought together around a shared purpose.”
The announcement also reflects a broader shift in how complex challenges must be approached. If Australia is serious about translating research, science and clinical insight into globally relevant solutions, then capital pathways, leadership capability and ecosystem infrastructure need to be developed together.
That has been central to the Foundation’s role, helping build the connective tissue between people, institutions and capital so that promising innovation can move beyond isolated success and towards broader public value.
The Synthesis Capital announcement is a timely reminder that Australia has deep capability in health and medtech innovation. The opportunity now is to ensure the systems around that capability are strong enough to help it scale.
_______________
To learn more about the announcement, read the Australian Financial Review article: HESTA backs new $70m venture capital fund to hunt medical tech stars.
At the Menzies Leadership Foundation, we exist to build the connective tissue between people, institutions and capital that makes this kind of systems change possible. If you are a leader working at the intersection of health innovation, investment and impact — or an organisation committed to strengthening Australia’s innovation ecosystem — we invite you to explore how the Foundation’s work and networks can support what you are building.
To learn more about the Foundation’s role in supporting science entrepreneurship and health innovation ecosystems, including our partnership with MedTech Actuator, we invite you to connect with us and stay engaged with the work we are doing to help promising ideas move from breakthrough to broader public value.


